With the Technology-Enabled Meaningful Patient Outcomes initiative, some digital health developers will offer devices for care covered by the CMS ACCESS model while monitoring for real-world performance.The U.S. Food and Drug Administration has launched a new initiative, the Technology-Enabled Meaningful Patient Outcomes for Digital Health Devices Pilot, or TEMPO. It’s designed as a voluntary effort […]
